Changes in blood coagulation and fibrinolysis in the nephrotic syndrome.
D000328:Adult; D000933:Antifibrinolytic Agents / Q000097:blood; D000991:Antithrombins / Q000378:metabolism; D001777:Blood Coagulation; D002784:Cholesterol / Q000378:metabolism; D005165:Factor V / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood* / Q000201:enzymology; D010958:Plasminogen / Q000032:analysis; D012709:Serum Albumin / Q000032:analysis; D000515:alpha 1-Antitrypsin / Q000032:analysis / Q000097:blood
D000933:Antifibrinolytic Agents; D000991:Antithrombins; D012709:Serum Albumin; D000515:alpha 1-Antitrypsin; D005165:Factor V; D005169:Factor VIII; D005340:Fibrinogen; D010958:Plasminogen; D002784:Cholesterol